cryoprecipitate

简明释义

英[ˌkraɪəʊprɪˈsɪpɪteɪt]美[ˌkraɪoʊprɪˈsɪpəˌteɪt]

n. 冷凝蛋白质；冷沉淀剂；沉淀物

英英释义

单词用法

同义词

反义词

例句

1.Fresh frozen plasma (FFP) and cryoprecipitate, often called "cryo" for short, are transfused to patients who have abnormal or low levels of blood clotting proteins, such as in hemophilia.

新鲜冷冻血浆及冷沉淀物(常简称为冷沉淀)可输给凝血因子异常或缺乏的患者(比如，血友病患者)。

2.Fresh frozen plasma (FFP) and cryoprecipitate, often called "cryo" for short, are transfused to patients who have abnormal or low levels of blood clotting proteins, such as in hemophilia.

新鲜冷冻血浆及冷沉淀物(常简称为冷沉淀)可输给凝血因子异常或缺乏的患者(比如，血友病患者)。

3.Conclusion: Combination of cryoprecipitate and prothrombin complex concentrate for traumatic hemorrhage has better effects than cryoprecipitate or prothrombin complex concentrate alone.

结论：联合应用冷沉淀与凝血酶原复合物在创伤性失血患者治疗中，联合输注组比单独输注组疗效更显著。

4.The intrapleural instillation of cryoprecipitate could significantly lower the recurrence rate of ipsilateral pneumothorax and could not lead to restrictive pulmonary dysfunction.

结论：胸膜腔内注入冷沉淀能有效地降低同侧气胸的复发率，且不会导致限制性肺功能障碍。

5.Conclusions platelet and cryoprecipitate can stanch abruptly in the treatment of the bleeding caused by DIC and get the time for the other therapeutic methods.

结论血小板、冷沉淀抢救DIC出血，可获得良好止血效果，为其他治疗措施提供了时机。

6.To study the cryoprecipitate infusion in the treatment of patients with massive blood loss efficacy.

探讨冷沉淀输注在大量失血患者治疗中的疗效。

7.A method of preparing the freeze - dried cryoprecipitate in the original plasma bags was introduced.

本文介绍一种在原血浆袋中冻干冷沉淀的方法。

8.Monitor fibrinogen levels and replace with cryoprecipitate if needed.

监测纤维蛋白原水平，如果需要输冷沉淀液。

9.The doctor ordered a transfusion of cryoprecipitate to help the patient with hemophilia.

医生为患有血友病的患者下令输注冷沉淀物。

10.After the blood was thawed, the lab technician separated the cryoprecipitate from the plasma.

在血液解冻后，实验室技术人员将冷沉淀物与血浆分开。

11.In cases of severe bleeding, cryoprecipitate can quickly replenish clotting factors.

在严重出血的情况下，冷沉淀物可以迅速补充凝血因子。

12.The emergency room stocked cryoprecipitate for patients needing urgent clotting support.

急诊室储备了冷沉淀物以供需要紧急凝血支持的患者使用。

13.Patients with low fibrinogen levels may require cryoprecipitate as part of their treatment.

纤维蛋白原水平低的患者可能需要将冷沉淀物作为治疗的一部分。

作文

In the field of medicine, particularly in hematology, the term cryoprecipitate refers to a component derived from blood plasma that is rich in clotting factors. When blood is frozen and then thawed, certain proteins precipitate out of the solution at low temperatures. This phenomenon is crucial for patients who suffer from bleeding disorders, such as hemophilia or von Willebrand disease. The use of cryoprecipitate has revolutionized the way we manage these conditions, allowing for targeted treatment that can significantly reduce the risk of severe bleeding episodes. The process of obtaining cryoprecipitate begins with the collection of whole blood, which is then subjected to a freezing process. After freezing, the blood is slowly thawed, causing the formation of a gelatinous substance that contains fibrinogen, factor VIII, and other essential clotting factors. These components are vital for the proper functioning of the coagulation cascade, which is responsible for stopping bleeding when injuries occur. By isolating and administering cryoprecipitate, healthcare providers can effectively restore the patient’s ability to form clots, thereby enhancing their overall health and safety. One of the significant advantages of using cryoprecipitate is its efficacy in treating patients with low fibrinogen levels. Fibrinogen is a protein that plays a critical role in blood clot formation. In cases of trauma, surgery, or liver disease, the levels of fibrinogen can drop dangerously low, leading to increased bleeding risks. Administering cryoprecipitate can quickly replenish these levels, providing immediate support to the patient’s hemostatic system. Moreover, cryoprecipitate is relatively easy to store and transport, making it a practical choice for blood banks and hospitals. It can be kept frozen until needed, allowing for a stable supply of this life-saving component. In emergency situations, where time is of the essence, the availability of cryoprecipitate can mean the difference between life and death for patients experiencing severe hemorrhage. Despite its benefits, the use of cryoprecipitate is not without risks. As with any blood product, there is the potential for transfusion reactions, which can range from mild allergic responses to more severe complications. Therefore, it is essential for healthcare professionals to carefully screen patients and monitor them during and after the administration of cryoprecipitate to ensure their safety. In conclusion, the term cryoprecipitate encapsulates a critical component in modern medicine that has transformed the approach to treating bleeding disorders. Its ability to provide essential clotting factors quickly and efficiently makes it an invaluable resource in both routine and emergency medical care. As research continues to advance in this area, we may discover even more applications for cryoprecipitate in improving patient outcomes and enhancing the quality of care in hematology and beyond.

在医学领域，特别是在血液学中，术语cryoprecipitate指的是从血浆中提取的一个成分，它富含凝血因子。当血液被冷冻后再解冻时，某些蛋白质会在低温下从溶液中沉淀出来。这一现象对于那些患有出血性疾病的患者至关重要，例如血友病或冯·维尔布兰德病。使用cryoprecipitate彻底改变了我们管理这些疾病的方法，使得针对性的治疗能够显著降低严重出血事件的风险。 获得cryoprecipitate的过程始于全血的采集，然后对其进行冷冻处理。冷冻后，血液缓慢解冻，形成一种含有纤维蛋白原、VIII因子和其他重要凝血因子的胶状物质。这些成分对凝血级联反应的正常功能至关重要，而该反应负责在受伤时止血。通过分离和施用cryoprecipitate，医疗提供者可以有效恢复患者的凝血能力，从而增强他们的整体健康和安全。 使用cryoprecipitate的一个显著优势是其在治疗纤维蛋白原水平低下的患者中的有效性。纤维蛋白原是一种在血液凝固形成中起关键作用的蛋白质。在创伤、手术或肝病的情况下，纤维蛋白原的水平可能会急剧下降，导致出血风险增加。施用cryoprecipitate可以迅速补充这些水平，为患者的止血系统提供即时支持。 此外，cryoprecipitate相对容易储存和运输，使其成为血液银行和医院的实用选择。它可以在需要时保持冷冻状态，从而为这一救命成分提供稳定的供应。在紧急情况下，时间至关重要，cryoprecipitate的可用性可能意味着经历严重出血的患者生与死之间的区别。 尽管有其好处，使用cryoprecipitate也并非没有风险。与任何血液产品一样，可能会发生输血反应，这可能从轻微的过敏反应到更严重的并发症。因此，医疗专业人员必须仔细筛查患者，并在施用cryoprecipitate期间和之后监测他们，以确保他们的安全。 总之，术语cryoprecipitate概括了现代医学中一个关键成分，该成分已转变为治疗出血性疾病的方法。它快速有效地提供必要的凝血因子的能力使其成为常规和紧急医疗护理中不可或缺的资源。随着这一领域研究的不断进展，我们可能会发现cryoprecipitate在改善患者结果和增强血液学及其他领域护理质量方面的更多应用。